Previous Article in Journal
Genetic Diversity of Leptospira Strains Circulating in Humans and in Free-Ranging Rats Indicates That Rats Are Not Sources of Human Leptospiroses in Hungary 2022–2025
Previous Article in Special Issue
Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study

1
Laboratory of Clinical Microbiology, Virology and Bioemergencies, Luigi Sacco Hospital, Regional Center for Infectious Diseases (CEREMI), Lombardy Region, 20157 Milan, Italy
2
Department of Infectious Disease, Luigi Sacco Hospital, Regional Center for Infectious Diseases (CEREMI), Lombardy Region, 20157 Milan, Italy
3
Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, 20157 Milan, Italy
4
Pathology Unit, Luigi Sacco Hospital, 20157 Milan, Italy
*
Author to whom correspondence should be addressed.
Pathogens 2026, 15(7), 730; https://doi.org/10.3390/pathogens15070730
Submission received: 8 June 2026 / Revised: 30 June 2026 / Accepted: 10 July 2026 / Published: 10 July 2026

Abstract

The clinical relevance of concurrent vaccine-preventable anal HPV genotype infections, particularly for short-term repeated detection and cytologic outcomes in screened high-risk populations, remains uncertain. We performed a single-centre retrospective study of 145 adults with at least one 9-valent vaccine-preventable anal HPV genotype at baseline and repeat HPV DNA testing and cytology approximately 12 months later. Baseline infections were classified as single- or multiple-genotype infections. Outcomes included clearance of all baseline vaccine-preventable genotypes, genotype-specific repeated detection, detection of new vaccine-preventable genotypes, complete HPV negativity, and cytologic regression or progression. At baseline, 70 participants (48.3%) had single and 75 (51.7%) had multiple genotype infections; most were male (95.2%) and people living with HIV (88.3%), reflecting a highly selected anal HPV-screened cohort. Multiple infections were associated with more frequent abnormal baseline cytology (69.3% vs. 45.7%). At follow-up, clearance of all baseline vaccine-preventable genotypes was more common after single than multiple infections (34.3% vs. 12.0%). Complete HPV negativity was also more frequent after single infection (24.3% vs. 4.0%), although this stringent endpoint is intrinsically more difficult to achieve in individuals with multiple baseline infections. New vaccine-preventable genotype detection did not differ significantly between groups. Genotype-specific repeated detection was generally similar between groups, except for HPV58, a finding based on small subgroup numbers. Cytologic regression was more frequent after single infection, but not statistically significant. Multiple vaccine-preventable anal HPV genotype infections were associated with greater baseline cytologic abnormality and lower clearance of baseline vaccine-preventable genotypes at 12 months. Given the retrospective design, selected population, limited event counts, and residual confounding, these findings should be interpreted as hypothesis-generating and do not prove impaired biological clearance.
Keywords: HPV; HPV16; repeated detection; cytology; PLWH; MSM HPV; HPV16; repeated detection; cytology; PLWH; MSM

Share and Cite

MDPI and ACS Style

Rizzo, A.; Moschese, D.; Salari, F.; Carsana, L.; Lazzarin, S.; Cavallo, A.; Fusetti, C.; Morelli, L.; Caruso, F.; Lombardi, A.; et al. Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study. Pathogens 2026, 15, 730. https://doi.org/10.3390/pathogens15070730

AMA Style

Rizzo A, Moschese D, Salari F, Carsana L, Lazzarin S, Cavallo A, Fusetti C, Morelli L, Caruso F, Lombardi A, et al. Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study. Pathogens. 2026; 15(7):730. https://doi.org/10.3390/pathogens15070730

Chicago/Turabian Style

Rizzo, Alberto, Davide Moschese, Federica Salari, Luca Carsana, Samuel Lazzarin, Andrea Cavallo, Chiara Fusetti, Loriana Morelli, Francesco Caruso, Alessandra Lombardi, and et al. 2026. "Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study" Pathogens 15, no. 7: 730. https://doi.org/10.3390/pathogens15070730

APA Style

Rizzo, A., Moschese, D., Salari, F., Carsana, L., Lazzarin, S., Cavallo, A., Fusetti, C., Morelli, L., Caruso, F., Lombardi, A., Giacomelli, A., Nebuloni, M., Dolci, A., & Gori, A. (2026). Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study. Pathogens, 15(7), 730. https://doi.org/10.3390/pathogens15070730

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop